Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Wednesday, February 17, 2021
Recro Pharma has announced key appointments to its management team and board of directors.
read more
Wednesday, February 17, 2021
Worldwide Clinical Trials announced Phillip Doyle will join as Global Head of Quality.
read more
Wednesday, February 17, 2021
Rentschler Biopharma announced the Company is establishing a Center of Excellence for cell and gene therapy, which will be located in Stevenage, UK.
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Wednesday, February 17, 2021
Evonik has announced an investment in short-term expansion of its specialty lipids production which are needed for mRNA-based COVID-19 vaccines.
read more
Wednesday, February 17, 2021
Samsung Biologics announced IND clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy.
read more
Tuesday, February 16, 2021
The CM Group has announced the acquisition of Scientific Commercialization, a Madison, Wisconsin-based business focused on medical affairs consulting and business intelligence software solutions.
read more
Tuesday, February 16, 2021
LipoMedix announced its lead compound, Promitil (PL-MLP), will be manufactured in the United States by ForDoz Pharma.
read more
Tuesday, February 16, 2021
Ubiquigent has entered into a license agreement with Medivir for Medivir’s preclinical USP7 research program.
read more
Tuesday, February 16, 2021
Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK.
read more
Friday, February 12, 2021
The newly formed life science group that resulted from the merger of clinical software vendors XClinical and Fortress Medical with social platform Carenity, announced to rename itself to EvidentIQ Group.
read more
Friday, February 12, 2021
endpoint Clinical has appointed Christine Hurley as its Senior Vice President, Client Services.
read more
Friday, February 12, 2021
BrainStorm recently concluded a Type C meeting with the FDA to review aspects of the company's planned manufacturing modifications to support the development of a semi-automated commercial manufacturing process for NurOwn.
read more
Friday, February 12, 2021
AzurRx BioPharma has entered into an agreement with PPD for its trial evaluating micronized niclosamide for COVID-19-associated GI infections.
read more